Moreover, Shyam et al. revealed that KEAP1 had homozygous mutations in some lung cancer cell lines, such as A549, H460, and H1435 cells42, suggesting that mutation Keap1 may weaken its ability to modulate the activity of Nrf2. This evidence concerns the gene NFE2L2 and lung carcinoma.